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The uncoupling protein from brown adipose tissue (UCP1) is a transporter that catalyzes a regulated discharged of the mitochondrial
proton gradient. The proton conductance in UCP1 is inhibited by nucleotides and activated by fatty acids. We have recently shown that all-
trans-retinoic acid (ATRA) is a high-affinity activator of UCP1. In the present report, we have set to analyze the structural requirements for
the ligands that activate UCP1 and particularly the specificity for different retinoids. For this purpose, we have developed a new protocol to
determine the activity of UCP1 in respiring yeast mitochondria that can be adapted for high-throughput screenings. Our results evidence
differences between the structural requirements for the activation by fatty acids and retinoids. Thus, although all active retinoids must possess
a carboxylate, the introduction of additional polar groups renders them inactive. The linear and rigid structure of these molecules suggests the
existence of a long hydrophobic binding pocket. We postulate that the access to the retinoid binding site must occur from the lipid bilayer and
this could be at the interface between two transmembrane a-helices.
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The uncoupling protein from brown adipose tissue
(UCP1) is a transporter of the mitochondrial inner mem-
brane whose function is the dissipation of the proton
gradient. The activity of UCP1 is tightly regulated. Purine
nucleotides bind to UCP1 from the cytosolic side and inhibit
the proton transport activity. Fatty acids can override the
nucleotide inhibition and increase the proton conductance.
The effects of these two regulatory ligands match with the
known events that take place during the physiological
activation of thermogenesis in the brown adipocyte. The
hypothalamus signals the initiation of thermogenesis
through the sympathetic nervous system. Noradrenaline
binds to h-receptors and initiates a cAMP-dependent lipo-
lytic cascade. The fatty acids liberated serve two functions:
they are the substrate that mitochondria will oxidize but also0005-2728/$ - see front matter D 2004 Elsevier B.V. All rights reserved.
doi:10.1016/j.bbabio.2004.05.010
Abbreviations: ATRA, all-trans-retinoic acid; UCP, uncoupling protein
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E-mail address: rial@cib.csic.es (E. Rial).the activators of UCP1. When the hormonal stimulation
ceases, lipolysis stops and once fatty acids are oxidized,
UCP1 will return to the nucleotide-inhibited state (reviewed
in Ref. [1]). We have recently described that all-trans-
retinoic acid (ATRA) is a high-affinity activator of UCP1
[2]. Interestingly, ATRA is also a powerful transcriptional
activator of the ucp1 gene and the concentration required to
increase the protein’s activity is within the range that
promotes gene expression [3]. Therefore, this regulatory
pathway could also be of physiological relevance.
Retinoids are generally defined as natural or synthetic
derivatives of vitamin A. The natural occurring retinoids
play important roles in a variety of biological processes such
as cell growth and differentiation, immune response, coag-
ulation, etc. Retinoids exert their action by binding to
nuclear receptors that act as ligand-activated transcription
factors (reviewed in Ref. [4]). Additionally, certain retinoids
have been shown to induce apoptosis through mechanisms
that seem independent of the nuclear receptors (reviewed in
Ref. [5]). Numerous synthetic retinoids have been devel-
oped with therapeutic aims. Thus, for example, retinoid-
based therapies are being used for the treatment of certain
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The description of the activation of UCP1 and UCP2 by
ATRA [2] has opened the door to the possible use of
retinoids to modulate the energetic efficiency at the mito-
chondrial level.
The yeast Saccharomyces cerevisiae has been used over
the last decade to investigate the transport properties of
recombinantly expressed UCP1 [7–9]. Since the discovery
of the new UCPs, S. cerevisiae has again been chosen by
several groups to investigate their bioenergetic properties
[10–12]. However, caution should be exerted when inter-
preting results obtained with the new UCPs in recombinant
systems [13]. In the present report, we present a fluorescent
method to determine the rate of respiration in isolated yeast
mitochondria that is applied to search for regulators of the
UCP1. The screening with a number of organic acids and
retinoids has provided valuable information on the transport
mechanism, the requirements for compounds to be active
and the nature of their binding site.2. Materials and methods
The procedures for recombinant expression of the rat
uncoupling protein UCP1 in the S. cerevisiae strain W303
have been described previously [7]. The control strain
contained the same vector but with the UCP1 cDNA in
the inverse orientation. Yeast growth and mitochondrial
isolation protocols have been described previously [7].
Protein was determined by the Lowry method using albumin
as standard.
The rate of mitochondrial respiration has been measured
using two techniques. The classic procedure uses a Hansa-
tech oxygen electrode (Hansatech Instruments, King’s Lynn,
England). Mitochondria (0.15 mg protein/ml) were incubat-
ed at 20 jC in medium containing 0.65 M mannitol, 0.5 mM
EGTA, 10 mM phosphate, 2 mM MgCl2, 1 mg/ml essen-
tially fatty-acid-free albumin and 10 mM Tris/maleate pH
6.8. Respiration was initiated by the addition of 1 mM
NADH. The second procedure is based on the monitorship
of the fluorescence decrease during the mitochondrial oxi-
dation of NADH. Experiments were performed on a stan-
dard uncoated 96-well microtiter plate (Nunc, Denmark).
Conditions were the same as for the oxygen electrode
experiments except that the concentration of NADH was
0.6 mM and the protein concentration 0.1 mg/ml. Regula-
tors (GDP, palmitate, retinoids, etc.) were added to the wells
before the NADH addition. Plates were read on a POLAR-
star Galaxy microplate reader (BMG Labtechnologies,
Offenburg, Germany). Excitation was set at 340 nm and
emission at 470 nm. To ensure homogeneity of the mito-
chondrial suspensions, plates were shaken for 10 s at the end
of each reading cycle.
The retinoids 4-[(E)-2-(5,6,7,8-tetrahydro-5,5,8,8-tetra-
methyl-2-naphtalenyl)-1-propenyl] benzoic acid (TTNPB)
and 4-[(5,6,7,8-tetrahydro-5,5,8,8-tetramethyl-2-naphtale-nyl)carboxamido] benzoic acid (AM580) were from Tocris
(Langford, UK). All other retinoids were synthesized at
Allergan and their structures shown in Fig. 2. Other organic
compounds tested were from Aldrich (Gillingham-Dorset,
UK) or Lancaster Synthesis (Morecambe, UK). All other
reagents were from Sigma (St. Louis, USA).3. Results and discussion
3.1. Screening protocol
Recombinant expression of the UCPs in yeasts and the
subsequent isolation of mitochondria has been widely used
to study their bioenergetic properties. An alternative pro-
cedure is the use of proteins reconstituted into liposomes.
The main advantage of the first system lies in the possi-
bility of performing studies in the presence of a high and
stable membrane potential that resembles closer the in vivo
conditions.
Plant and yeast mitochondria present a distinct feature
from mammalian mitochondria, namely their ability to
oxidize cytosolic NAD(P)H. NAD(P)H presents an absorp-
tion band at 340 nm that disappears when the coenzymes are
oxidized. Additionally, the light absorbed at 340 nm is
emitted as fluorescent light with a maximum at 460 nm.
Therefore, changes in absorption or fluorescence can be
used to follow variations in the redox state of these
coenzymes. We have used this approach to measure the rate
of respiration of S. cerevisiae mitochondria and determine
the activity of UCP1. Thus, Fig. 1 shows the effects of
nucleotides and fatty acids on UCP1 mitochondria (A and
C) and are compared with those on control mitochondria (B
and D). The fluorescence data (A and B) can be converted to
NADH concentration values (C and D) after signal calibra-
tion. The slope of the regression lines are the rates of NADH
consumption and these values are summarized in Table 1.
This methodology confirms the known bioenergetic
properties of UCP1. Thus, basal respiration is higher for
mitochondria from UCP1 expressing yeasts than for control
(Table 1) and this difference reflects the basal proton
transport activity of UCP1. This UCP1-dependent proton
flux can be inhibited with GDP and then the respiratory rate
becomes indistinguishable from that of control yeasts. As
expected, the rate of fluorescence decrease is faster in the
presence of palmitate and can be inhibited with GDP. Table
1 also shows that there is a perfect agreement between of the
data generated with the microplate reader and those obtained
with the oxygen electrode.
3.2. Activation of UCP1 by organic acids
Fatty acids activate the uncoupling protein UCP1 but the
molecular mechanism has remained controversial for a long
time [14]. Two models have been put forward to explain
the activity of UCP1 where fatty acids operate as either
Fig. 1. Analysis with a microplate reader of the regulation of the uncoupling protein UCP1. (A and B) Fluorescence decrease; (C and D) NADH consumption.
Panels A and C show the analysis on mitochondria from UCP1 expressing yeasts while panels B and D correspond to control yeasts. (.) Basal respiration; (x)
48 AM palmitate present; (5) 1 mM GDP present; (D) in the presence of 48 AM palmitate and 1 mM GDP. Dashed lines in panels C and D represent the linear
regression and the slopes are summarized in Table 1. Data are the average of the readings of three plate wells.
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group (‘‘proton buffering model’’). The first hypothesis
proposes the existence of a cycle where the protonated fatty
acid would flip-flop in the membrane to deliver a proton to
the matrix side and UCP1 would catalyze the return of the
fatty acid anion to the cytosolic side of the membrane. In theTable 1
Comparison of the rates of respiration of yeast mitochondria measured with an o
UCP1 Mitochondria
Oxygen consumptiona NADH co
Basal respiration 218 223
Uncoupled respiration 773 675
GDP 3 mM 149 142
Palmitate 48 AM 337 349
Palmitate 48 AM+GDP 3 mM 140 147
Determinations were performed with the same mitochondrial preparations. Oxyg
oxidation rates are the average of values obtained with three plate wells. Uncoup
a Values in nanomoles of ‘O’ consumed per minute and per milligram of prot
b Values in nanomoles of NADH consumed per minute and per milligram ofalternative mechanism, fatty acids act as a prosthetic group
in UCP1: the carboxylate would bind protons and deliver
them to a site from which they are translocated to the other
side of the membrane. We have recently demonstrated
that undecanosulfonate can activate UCP1 [14] and since
liposome studies have shown that alkylsulfonates cannotxygen electrode or a fluorescence microplate reader
Control Mitochondria






en consumption measurements were performed in duplicate while NADH
led respiration was determined in the presence of 10 AM FCCP.
ein. The oxygen content at 20 jC is considered to be 284 nmol/ml.
protein.
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cannot explain the transport mechanism.
The investigation of the specificity of the UCP1 activa-
tors could also help to unravel the mechanism of activation.
The structural requirements for the activators do not appear
to be very stringent; thus, compounds with a free carbox-
ylate group and with sufficient lipid solubility will increase
its proton conductance [16–19]. There are, however, dis-
crepancies in the data available. A second carboxylate in the
N position seems tolerated in the hands of some authors [19]
but not others [18]. A similar situation is found with the
presence of aromatic rings in the molecule. There is a
consensus on the acceptance of bulky groups along the
aliphatic chain but there is disagreement if they are present
at the end of the tail. Thus, Jezek et al. [18] have shown that
4-heptyl-benzoic increases the UCP1-mediated proton trans-Fig. 2. Structure of the compounds tested. Compoundport in liposomes while 6-phenyl-hexanoic did not. How-
ever, Klingenberg and Huang [19], also working with
proteoliposomes, see a moderate proton transport with 6-
phenyl-hexanoic but it is markedly increased when 8-phe-
nyl-octanoic is used. We have also reported that ATRA is a
strong activator despite the presence of a planar-bulky
structure far from the carboxylate [2].
To investigate the structural requirements of aromatic
compounds to activate UCP1 further, we have used the new
screening protocol that relies on measurements under re-
spiring conditions. Fig. 2 presents the structural formula of
the compounds tested and Fig. 3 the results of the screening.
As we have previously reported [2] ATRA presents a high
affinity although the kinetics shows saturation with a
maximum respiratory activity lower than that induced by
palmitate. Compounds that elicit a respiration increase lowers that activate UCP1 are included in the boxes.
Fig. 3. Activation of UCP1 by organic acids. The two top panels present the effect of palmitate (left) and ATRA (right) on control mitochondria (o) and
mitochondria expressing UCP1 (.). In the rest of the panels, only the effects on UCP1 mitochondria are shown. Albumin concentration was 1.6 AM. Data
points represent the meanF S.E. of two to three independent experiments performed at least in duplicate.
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pounds generally causes a 10–20% increase in respiration
in control mitochondria (data not shown). The results
obtained with these organic compounds are in good agree-
ment with those published by Jezek et al. [18]. Thus, for
example in our system 4-hexyl-benzoic is active while 6-
phenyl-hexanoic is not. Interestingly, the kinetics of hexyl-
benzoic resembles that of retinoic acid. A number of other
compounds with benzene rings distant from the carboxylate
were also inactive. Our screening protocol also portrays
trans-cinnamic acid as an inactive molecule and therefore
contradicts the observations reported by Echtay et al. [20].
3.3. Activation of UCP1 by retinoids
The activation of UCP1 by ATRA would seem puzzling
in view of the structure of the activators shown in Fig. 3 and
in Ref. [18]. Since a large collection of compounds struc-
turally related to retinoic acid have been synthesized as
specific ligands for retinoid receptors, we decided to screen
a set of these compounds to get an insight into the structural
requirements of the activators of the UCP1 and their binding
site. A first selection of compounds had to be made by
analyzing their effects on control yeast mitochondria. Our
screening protocol was particularly useful for this task. A
significant proportion of the retinoids could not be used to
investigate their activity as regulators of UCP1 because of
their unspecific effects on control mitochondria. Thus, some
compounds showed uncoupling activity, others were inhib-itors of respiration and some retinoids showed these two
effects depending on their concentration (data not shown).
Data collected in Fig. 4 are for those compounds that gave
unequivocal effects on yeast mitochondria expressing
UCP1. Thus, for example, ATRA (Fig. 3) or AGN
191547 (Fig. 4) causes a mild inhibition of respiration in
control yeasts but activation of UCP1 can be clearly
established. Similarly, the uncoupling activity of AGN
193776 or AGN 199907 could be easily differentiated from
the effects on UCP1. The rate of respiration in the presence
of GDP (Fig. 5) also reflects the UCP-independent activity;
hence, the smaller bars in ATRA, TTNPB or AGN 181547
confirm the inhibition of respiration seen in control mito-
chondria. In fact, the GDP-sensitive component (difference
between the two bars) is a more realistic measure of the
relative activity of the retinoids. Nevertheless, the distinc-
tion between active and inactive retinoids for this set of
compounds is evident.
The first observation that should be pointed out is that
when the carboxylate group of the retinoid was replaced by a
hydroxyl or carbonyl group (AGN 197053, AGN 197664 or
AGN 197901), the compounds are inactive. The need for a
free carboxylate was pointed out 20 years ago after the
analysis with fatty acid derivatives [16]. This requirement
was confirmed by other authors [17,18] and has been inter-
preted as an indication of the involvement of the carboxylate
in proton translocation, no matter the regulatory model
invoked. This notion has recently been challenged by Echtay
et al. [20] who reported that retinal or 4-hydroxy-nonenal
Fig. 4. Activation of UCP1 by retinoids. In all cases, filled symbols (.,n,E) correspond to the data obtained with mitochondria from UCP1 expressing yeasts
and empty circles with control yeast mitochondria. Albumin concentration was 1.6 AM. Data points represent the meanF S.E. of two to three independent
experiments performed at least in duplicate.
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UCP2, UCP3 and the ADP/ATP carrier. These authors
suggest that the activation by these compounds is due to
the reaction of the functional group 2-alkenal with specific
residues in the UCPs or the ADP/ATP carrier. This mecha-
nism cannot be invoked for the activation of UCP1 in brownfat where fatty acids are the physiological regulators and this
functional group is not present in them.
The second feature that should be highlighted concerns
the effect of polar groups in the retinoid molecule. The
analysis of the fatty acid specificity revealed a remarkable
tolerance to the presence of hydrophilic substituents if a
Fig. 5. Nucleotide sensitivity of the activation of UCP1 by retinoids. Bars
represent the meanF S.E. of two to three independent experiments
performed at least in duplicate. The dashed horizontal line represents the
basal rate of respiration and it represents the mean value of the respiratory
rates in the absence of the effectors. The concentration of the different
retinoids was the highest presented in Fig. 4. Empty bars represent the rates
of respiration in the presence of retinoid while filled bars are the rates
obtained at the same retinoid concentration but in the presence of 3 mM
GDP.
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provided by the screening with the retinoids points to a
different situation since the presence of polar groups is not
tolerated. One good example is the comparison between
TTNPB and AM580 (see structures in Fig. 2). TTNPB is the
retinoid that shows the highest affinity and the substitution
of the central propenyl by an amide (AM580) leads to the
complete loss of activity. A similar conclusion can be drawn
after the comparison of AGN 190121 and AGN 191859
where the substitution of two methyl groups by a carbonyl
also leads to an inactive retinoid.
The activation of UCP1 by retinoids starts to provide
information on their binding site. Most of the active reti-
noids presented in Fig. 2 are extended molecules with little
flexibility that would require the presence of a binding
pocket with a length of at least 15 A˚. The clear hydrophobic
profile of these compounds would suggest the access to the
binding site from the lipid bilayer. We have previously
reported that photoaffinity labelling of UCP1 with ATRA
is increased in the presence of ubiquinone [21]. Ubiquinone
has been postulated as an essential cofactor for the activity
of UCP1 [22] although this view has been challenged
[23,24]. We can envisage that ubiquinone facilitates or
participates in binding of the retinoids to UCP1 and that
this binding occurs by lateral diffusion from the lipid phase
of the membrane.
The 3D structure of the UCP1 is not known. We have
presented a model for the transmembrane arrangement ofthe UCP1 that proposes the existence of an a-helix bundle
formed by the six transmembrane domains that spans the
hydrophobic core of the membrane to form the main
translocation pathway [25]. This arrangement has recently
been confirmed with the publication of the 3D structure of
the ADP/ATP carrier [26]. We now postulate that this
retinoid binding pocket could be located at the interface
between two transmembrane a-helices. The establishment
of the tight binding of the retinoids, deduced from their high
affinity, would suggest a predominance of strong hydropho-
bic interactions and therefore an exclusion of compounds
that present marked polar residues in their structure.
The final question concerns the relation between the
retinoid binding site and the fatty acid binding site. We
have previously reported that the activation effects of ATRA
and palmitate are neither synergistic nor additive and that,
therefore, they must be acting on the same site [2]. These
new data suggest that the two types of ligands must differ in
their mechanism of binding although the functional carbox-
ylate group may end up in the same site to fulfill its
regulatory function. Indeed, it is striking, first, the difference
in the activation kinetics that for all retinoids saturating with
a Vmax markedly lower than that of fatty acids and, secondly,
the difference in the tolerance for hydrophilic substituents.4. Concluding remarks
We have demonstrated that the use of a microplate reader
is well suited to follow the respiration of yeast mitochon-
dria. We have applied this methodology to screen for
compounds that activate UCP1. For the present assays, a
96-well microtiter plate has been used with 120 Al per well.
Since the molar extinction coefficient and the quantum yield
of the NADH fluorescence are very high, assay volumes can
be decreased markedly without compromising the quality of
the signal. Similarly, the protein concentration can also be
decreased significantly if the reading time is increased
accordingly. These two features are an indication that the
procedure can be easily adapted to the requirements of a
high throughput screening protocol.
We have reported that undecanosulfonate activates pro-
ton transport in UCP1 and since this compound cannot
flip-flop, the fatty acid cycling hypothesis cannot be the
mechanism that explains the increased membrane proton
conductance [16]. The flip-flop capacity of different or-
ganic acids has been investigated in liposomes [27]. These
studies revealed that compounds with aromatic rings, such
as 6-phenyl-hexanoic, biphenyl-2-carboxylic, 2-naphtoic or
3,3-diphenyl-propionic, were unable to flip-flop. It has
been argued that this could be due to the bulkiness and
planar structure of the benzene ring [27]. Some active
retinoids used in our study present structural features that
would make unlikely their flip-flop in the membrane and,
therefore, it is an additional argument against the fatty acid
cycling hypothesis.
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